After affirmative action ban, medical educators see a silver lining; what to know about U.S. malaria cases

Some medical school and educational leaders are hopeful that a path exists for them to diversify future classes and the health workforce.

June 30, 2023 Check out STAT+

Sponsored By

Anna Moneymaker/Getty Images After affirmative action ruling, medical education leaders see silver lining in court endorsement of 'holistic review' Educators saw the Supreme Court decision as endorsing the use of a tool used by medical, dental, and nursing schools to diversify classes. By Usha Lee McFarling Malaria cases in Florida and Texas: Here's what you need to know Scientists say five cases of locally-transmitted malaria in Florida and Texas are concerning but not cause for alarm. By Simar S. Bajaj STAT+ | Medicare details the structure of its new drug price negotiation program Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it's set to start. By Rachel Cohrs and Sarah Owermohle and John Wilkerson Dr. Edwin P. Ewing, Jr./CDC For Duchenne moms who pushed for cures, new breakthrough therapy can't rebuild what's lost Their sons paved the way for approval of Sarepta Therapeutics' gene therapy, Elevidys — but only for younger patients. By Jason Mast Opinion: The Supreme Court's affirmative action decision puts lives at risk The affirmative action ban comes as health disparities in the U.S. worsen. Medical schools should take these steps to encourage diversity. By Jessica Faiz and Utibe R. Essien and Donna L. Washington STAT+ | Medicare's new proposal to cover medical devices draws a mixed reaction Medical device makers have long complained that the rocky road to Medicare reimbursement kills innovative companies. By Lizzy Lawrence Adobe STAT+ | Bright Health sells Medicare Advantage plans to Molina for $600 million Bright Health Group has agreed to sell its Medicare Advantage plans to Molina Healthcare for $600 million. By Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser